Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s SFDA Rapid Response To Biopharmaceutical-Triggered Deaths Seen As Progress By Industry Observers

This article was originally published in PharmAsia News

Executive Summary

BEIJING - In a case that closely parallels FDA's investigation of the drug heparin, China's State FDA is now examining a biopharmaceutical that triggered severe adverse reactions in seven Chinese patients, six of whom have died

You may also be interested in...



China’s State FDA Loses Independence in Merger With Ministry Of Health

BEIJING - In a major revamping of China's drug regulatory system, China's State FDA will lose part of its rule-making authority during an ongoing merger with the Ministry of Health

China’s State FDA Loses Independence in Merger With Ministry Of Health

BEIJING - In a major revamping of China's drug regulatory system, China's State FDA will lose part of its rule-making authority during an ongoing merger with the Ministry of Health

China’s SFDA To Require Electronic Tags For All Domestic Drugs; Imported Pharmaceuticals Likely To Follow

BEIJING - China's State FDA has issued a series of regulations in recent months that will ultimately require all pharmaceuticals, biologics and medical devices produced domestically to carry electronic tags with essential identifying information

Related Content

UsernamePublicRestriction

Register

LL1130096

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel